Nicole M Janson

This inventor holds 9 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Alderbio Holdings LLC, H. Lundbeck A/s. Active years: 2017-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicole M Janson. Retrieved from https://idiyas.com/inventor/nicole-m-janson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 9.3

ph-index = 7

Forward Citations = 91(Granted Patents)

Location History:

Seattle, WA (US) (2018 - 2021)
Edmonds, WA (US) (2017 - 2022)

Company Filing History:

7 out of 98

Alderbio Holdings LLC

Years Active: 2017-2022

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11214610 - High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as (2022-01-04),

2. 11111289 - Anti-CGRP compositions and use thereof (2021-09-07),

3. 10533048 - Anti-CGRP compositions and use thereof (2020-01-14),

4. 10214582 - Anti-CGRP compositions and use thereof (2019-02-26),

5. 10208112 - Anti-CGRP compositions and use thereof (2019-02-19),

6. 10189895 - Anti-CGRP compositions and use thereof (2019-01-29),

7. 10179809 - Anti-CGRP compositions and use thereof (2019-01-15),

8. 10066009 - Anti-CGRP compositions and use thereof (2018-09-04),

9. 9745373 - Anti-CGRP compositions and use thereof (2017-08-29),

Title: Innovations and Contributions of Nicole M Janson

Introduction

Nicole M Janson is a prominent inventor based in Seattle, WA, known for her significant contributions to the field of biotechnology. With a total of nine patents to her name, she has made remarkable advancements in the production of multi-subunit proteins, particularly antibodies. Her work has implications for various medical applications, showcasing her expertise and innovative spirit.

Latest Patents

Among her latest patents, Janson has developed methods for the high-purity production of multi-subunit proteins, including antibodies, in transformed microbes. One notable patent focuses on improved methods for producing heterologous multi-subunit proteins in transformed cells, which enhances yield and reduces undesired side-products. Another significant invention involves anti-CGRP compositions, which are directed towards antibodies and fragments that specifically bind to CGRP. This invention also includes methods for diagnosing and treating diseases associated with CGRP, highlighting her contributions to medical science.

Career Highlights

Throughout her career, Nicole M Janson has worked with notable companies such as Alderbio Holdings LLC and H. Lundbeck A/S. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects, further solidifying her reputation as an innovative inventor in the biotechnology sector.

Collaborations

Janson has collaborated with esteemed colleagues, including Leon F Garcia-Martinez and John A Latham. These partnerships have contributed to her success and the advancement of her research initiatives.

Conclusion

Nicole M Janson's innovative work in the field of biotechnology, particularly in the production of multi-subunit proteins and antibodies, has made a significant impact on medical research and treatment. Her contributions continue to inspire future advancements in the industry.

Profile summary based on public USPTO records.